Based on single cell clonogenic data, it has been proposed that a sequential acquisition of genetic lesions with SF3B1 in one of the mutated major clones at the early stages of MDS is implicated for subsequent AML transformation [103]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.